GLP-1’s improve cervical fusion rates.

By

But wait there's more. GLP-1s continue to bring miracles.

The new study, "Fusion Outcomes of GLP-1 Agonist Therapy in Multilevel Cervical Spinal Fusion: A Propensity-Matched Analysis" (Vatsia et al., PMID: 40042198), dives into the impact of GLP-1 agonist therapy on pseudarthrosis rates in multilevel cervical spine fusion. Given the growing use of GLP-1 agonists like semaglutide and liraglutide for managing obesity and diabetes—conditions often seen in our patient population—this retrospective analysis is highly relevant to the fusion space.
PubMed article - Fusion Outcomes of GLP-1 Agoni...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.